When was GenXys founded?

GenXys was founded in 2014 and raised its 1st funding round 5 years after it was founded.

Where is GenXys located?

GenXys is headquartered in Vancouver, Canada. It is registered at 800 - 885 West Georgia Street, Vancouver.

Who is the current CEO of GenXys?

Martin Dawes and Lloyd Wilhelms s of GenXys. Martin Dawes has also founded 1 company.

How many employees does GenXys have?

As of Sep 30, 2026, the latest employee count at GenXys is 18.

Is GenXys a funded company?

GenXys is a funded company, having raised a total of $4.33M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 03, 2019.

When was the latest funding round of GenXys?

GenXys' latest funding was a $***** Seed round on Mar 01, 2021, with participation from 5 investors.

Where does GenXys rank among its competitors?

GenXys ranks 2nd amongst 90 active competitors, of which 12 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Vesynta, which secured $306K in Apr, 2024.

Who are the top competitors of GenXys?

GenXys' top competitors include Tabula Rasa Healthcare, DoseMe and Monarch Medical Technologies. Among them, Vesynta secured the most recent funding round in April, 2024.

GenXys - 2026 Company Profile, Team, Funding & Competitors

GenXys is a seed company based in Vancouver (Canada), founded in 2014 by Martin Dawes. It operates as a Provider of pharmacogenetic testing and a medication decision support system. GenXys has raised $4.33M in funding from investors like GSC, TELUS Ventures and TYDO INCUBATOR. The company has 90 active competitors, including 12 funded and 7 that have exited. Its top competitors include companies like Tabula Rasa Healthcare, DoseMe and Monarch Medical Technologies.

Company Details

Provider of pharmacogenetic testing and a medication decision support system. The company offers TreatGxPlus, a home collection kit that can be ordered by consumers for Pharmacogenetic testing, and the company provides a report on genetic variants that may affect body responses to medications. These results can be shared with a healthcare professional to facilitate shared decision-making on medication options between the user and the healthcare professional. The company also offers TreatGx, a medication decision support tool for healthcare professionals that provides personalized medication options by combining pharmacogenetic and medical information with the best clinical evidence.

Website: www.genxys.com/
Social
Email ID: *****@genxys.com
Phone Number: +1 **********
Registered Address: 800 - 885 West Georgia Street, Vancouver

Key Metrics

Founded Year

2014

Location

Vancouver, Canada

Stage

Seed

Total Funding

$4.33M in 3 rounds

Latest Funding Round

Seed, Mar 01, 2021, $*****

Investors

GSC & 7 more

Ranked

2^nd among 90 active competitors

Employee Count

18 as on Sep 30, 2026

Similar Companies

Tabula Rasa Healthcare & 104 more

View GenXys' full profile

GenXys is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
GenXys Health Care Systems Inc. CIN: 894806-2 , Canada, Active	Jul 09, 2014	-	-	-

GenXys has raised a total funding of $4.33M over 3 rounds. Its first funding round was on Apr 03, 2019. Its latest funding round was a Seed round on Mar 01, 2021 for $*****. 5 investors participated in its latest round. GenXys has 8 institutional investors.

Here is the list of recent funding rounds of GenXys:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 01, 2021	4644278	Seed	8480100	5596847	1782043	8852840
May 26, 2020	6111174	Seed	4941326	1154363	4236565	9722465
Apr 03, 2019	8597735	Seed	6770007	5700777	TYDO INCUBATOR & 1 more	9703931

Access funding benchmarks and valuations. Sign up today!

View details of GenXys's funding rounds and investors

The founders of GenXys is Martin Dawes. Martin Dawes is the CEO of GenXys.

Here are the details of GenXys' key team members:

Martin Dawes: Founder & CEO of GenXys. They serve on the board of 1 company.
Contact Info: 1 email address
Lloyd Wilhelms: CEO of GenXys.

GenXys' Board of Directors

GenXys's board has 4 active members. Martin Dawes, Mark Gelfer, Martin Cheski and Bernard Esquivel are independent board members.

Here is the list of GenXys' board of directors:

Name	Type	Representing	Status	Duration
Martin Dawes	Independent board member	-	Current	12y 2m
yoljxqw	Independent board member	-	Current	9y 5m
pj{xjui	Independent board member	-	Current	2y 1m
choaxh{	Independent board member	-	Current	6y 9m

View details of GenXys's Founder profiles and Board Members

GenXys' employee count trend

GenXys has 18 employees as of Sep 26. Here is GenXys's employee count trend over the years:

Uncover GenXys' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GenXys include Tabula Rasa Healthcare, DoseMe and Monarch Medical Technologies. Here is the list of Top 10 competitors of GenXys, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tabula Rasa Healthcare 2013, Moorestown (United States), Public	Provider of cloud-based data-driven medication risk optimization solutions for healthcare organizations	-	Western Alliance Bank, Originate Ventures ... & 4 others	55/100
2nd	GenXys 2014, Vancouver (Canada), Seed	Provider of pharmacogenetic testing and a medication decision support system	$4.33M	TELUS Ventures, Esplanade Ventures & 6 others	49/100
3rd	DoseMe 2014, Houston (United States), Acquired	Precision Bayesian dosing platform improving patient outcomes and lowering healthcare costs	-	Transition Level	50/100
4th	Monarch Medical Technologies 2003, Charlotte (United States), Acquired	Provider of clinical decision support software for inpatient glucose management	$5M	Semler Scientific	48/100
5th	Assurex Health 2006, Mason (United States), Acquired	Personalized neuropsychiatric medicine	$84.5M	Claremont Creek Ventures, Four Rivers Group ... & 16 others	47/100
6th	MedEye 2010, s Hertogenbosch (Netherlands), Series B	Online platform offering healthcare medication safety suite for hospitals	$12M	Life Sciences Partners, Seventure Partners ... & 5 others	46/100
7th	InsightRx 2015, San Francisco (United States), Series A	Analytics platform for precision dosing	$13.2M	GreatPoint Ventures, HealthX Ventures & 15 others	43/100
8th	Hygieia 2007, Ann Arbor (United States), Series A	Provider of insulin dosage and medication guidance system	$5.79M	Oakwood Medical, Blue Cross Blue Shield of Michigan ... & 7 others	43/100
9th	CureMatch 2015, San Diego (United States), Seed	Precision oncology: AI-powered treatment matching for personalized cancer care	-	Serra Ventures, Analytics Ventures & 1 others	41/100
10th	Vesynta 2018, Sutton (United Kingdom), Seed	Provider of a data-guided precision dosing platform focusing on personalized treatment	$306K	SFC Capital, o2h ventures & 2 others	40/100